(QLYS) Qualys - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US74758T3032
Stock: Cloud, Vulnerability, Compliance, Endpoint, Container
Total Rating 46
Risk 87
Buy Signal -0.26
| Risk 5d forecast | |
|---|---|
| Volatility | 34.9% |
| Relative Tail Risk | -7.37% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.61 |
| Alpha | -42.51 |
| Character TTM | |
|---|---|
| Beta | 0.960 |
| Beta Downside | 2.077 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.91% |
| CAGR/Max DD | -0.10 |
EPS (Earnings per Share)
Revenue
Description: QLYS Qualys February 25, 2026
Qualys, Inc. (NASDAQ: QLYS) operates a cloud-native platform that unifies IT, security, and compliance functions, delivering a broad menu of services-from vulnerability management and asset discovery to cloud workload protection and container security-through its Enterprise TruRisk platform.
In the latest fiscal year, Qualys reported $1.13 billion in revenue, a 9% year-over-year increase, and grew its subscription-based Annual Recurring Revenue (ARR) to $1.01 billion, reflecting strong demand for integrated, cloud-first security solutions.
The company benefits from macro-level drivers such as the surge in remote work, tightening data-privacy regulations, and the accelerating migration of workloads to public clouds, all of which are expanding the global cloud-security market at an estimated 13% compound annual growth rate through 2028.
Qualys serves a diversified client base-including enterprises, government agencies, and SMBs-across sectors like financial services, healthcare, and technology, leveraging both direct sales and a channel network of MSPs, resellers, and cloud providers.
For a deeper dive into valuation metrics, consider exploring ValueRays analysis.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 198.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.28 > 0.02 and ΔFCF/TA 3.99 > 1.0 |
| NWC/Revenue: 28.44% < 20% (prev 25.89%; Δ 2.55% < -1%) |
| CFO/TA 0.28 > 3% & CFO 309.4m > Net Income 198.3m |
| Net Debt (-153.0m) to EBITDA (247.4m): -0.62 < 3 |
| Current Ratio: 1.41 > 1.5 & < 3 |
| Outstanding Shares: last quarter (36.1m) vs 12m ago -2.32% < -2% |
| Gross Margin: 82.85% > 18% (prev 0.82%; Δ 8203 % > 0.5%) |
| Asset Turnover: 64.69% > 50% (prev 62.41%; Δ 2.28% > 0%) |
| Interest Coverage Ratio: -16.68 > 6 (EBITDA TTM 247.4m / Interest Expense TTM -14.0m) |
Altman Z'' 1.82
| A: 0.17 (Total Current Assets 657.6m - Total Current Liabilities 467.3m) / Total Assets 1.10b |
| B: -0.15 (Retained Earnings -166.7m / Total Assets 1.10b) |
| C: 0.23 (EBIT TTM 232.9m / Avg Total Assets 1.03b) |
| D: -0.32 (Book Value of Equity -170.6m / Total Liabilities 533.9m) |
| Altman-Z'' Score: 1.82 = BBB |
Beneish M -3.10
| DSRI: 0.94 (Receivables 171.0m/164.6m, Revenue 669.1m/607.6m) |
| GMI: 0.99 (GM 82.85% / 81.65%) |
| AQI: 1.03 (AQ_t 0.34 / AQ_t-1 0.33) |
| SGI: 1.10 (Revenue 669.1m / 607.6m) |
| TATA: -0.10 (NI 198.3m - CFO 309.4m) / TA 1.10b) |
| Beneish M-Score: -3.10 (Cap -4..+1) = AA |
What is the price of QLYS shares?
As of March 07, 2026, the stock is trading at USD 99.45 with a total of 580,552 shares traded.
Over the past week, the price has changed by +6.16%, over one month by -22.19%, over three months by -31.92% and over the past year by -24.44%.
Over the past week, the price has changed by +6.16%, over one month by -22.19%, over three months by -31.92% and over the past year by -24.44%.
Is QLYS a buy, sell or hold?
Qualys has received a consensus analysts rating of 3.17.
Therefor, it is recommend to hold QLYS.
- StrongBuy: 4
- Buy: 0
- Hold: 16
- Sell: 2
- StrongSell: 1
What are the forecasts/targets for the QLYS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 138.5 | 39.3% |
| Analysts Target Price | 138.5 | 39.3% |
QLYS Fundamental Data Overview March 05, 2026
P/E Trailing = 17.9026
P/E Forward = 12.8205
P/S = 5.2191
P/B = 6.0137
P/EG = 4.4197
Revenue TTM = 669.1m USD
EBIT TTM = 232.9m USD
EBITDA TTM = 247.4m USD
Long Term Debt = 52.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 7.32m USD (from shortTermDebt, last quarter)
Debt = 97.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -153.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.14b USD (3.49b + Debt 97.2m - CCE 445.9m)
Interest Coverage Ratio = -16.68 (Ebit TTM 232.9m / Interest Expense TTM -14.0m)
EV/FCF = 10.33x (Enterprise Value 3.14b / FCF TTM 304.4m)
FCF Yield = 9.68% (FCF TTM 304.4m / Enterprise Value 3.14b)
FCF Margin = 45.49% (FCF TTM 304.4m / Revenue TTM 669.1m)
Net Margin = 29.64% (Net Income TTM 198.3m / Revenue TTM 669.1m)
Gross Margin = 82.85% ((Revenue TTM 669.1m - Cost of Revenue TTM 114.8m) / Revenue TTM)
Gross Margin QoQ = 83.36% (prev 83.64%)
Tobins Q-Ratio = 2.87 (Enterprise Value 3.14b / Total Assets 1.10b)
Interest Expense / Debt = 2.24% (Interest Expense 2.18m / Debt 97.2m)
Taxrate = 17.50% (11.3m / 64.4m)
NOPAT = 192.1m (EBIT 232.9m * (1 - 17.50%))
Current Ratio = 1.41 (Total Current Assets 657.6m / Total Current Liabilities 467.3m)
Debt / Equity = 0.17 (Debt 97.2m / totalStockholderEquity, last quarter 561.2m)
Debt / EBITDA = -0.62 (Net Debt -153.0m / EBITDA 247.4m)
Debt / FCF = -0.50 (Net Debt -153.0m / FCF TTM 304.4m)
Total Stockholder Equity = 524.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 19.17% (Net Income 198.3m / Total Assets 1.10b)
RoE = 37.83% (Net Income TTM 198.3m / Total Stockholder Equity 524.2m)
RoCE = 40.40% (EBIT 232.9m / Capital Employed (Equity 524.2m + L.T.Debt 52.3m))
RoIC = 36.65% (NOPAT 192.1m / Invested Capital 524.2m)
WACC = 9.04% (E(3.49b)/V(3.59b) * Re(9.24%) + D(97.2m)/V(3.59b) * Rd(2.24%) * (1-Tc(0.18)))
Discount Rate = 9.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.15%
[DCF] Terminal Value 76.11% ; FCFF base≈275.4m ; Y1≈307.5m ; Y5≈406.1m
[DCF] Fair Price = 166.9 (EV 5.80b - Net Debt -153.0m = Equity 5.95b / Shares 35.7m; r=9.04% [WACC]; 5y FCF grow 13.52% → 2.90% )
EPS Correlation: 96.16 | EPS CAGR: 21.90% | SUE: 1.87 | # QB: 16
Revenue Correlation: 98.98 | Revenue CAGR: 12.31% | SUE: 1.22 | # QB: 2
EPS next Quarter (2026-06-30): EPS=1.79 | Chg7d=-0.014 | Chg30d=-0.013 | Revisions Net=-3 | Analysts=22
EPS current Year (2026-12-31): EPS=7.38 | Chg7d=+0.000 | Chg30d=-0.002 | Revisions Net=+2 | Growth EPS=+4.4% | Growth Revenue=+7.8%
EPS next Year (2027-12-31): EPS=7.98 | Chg7d=+0.000 | Chg30d=+0.122 | Revisions Net=+7 | Growth EPS=+8.1% | Growth Revenue=+7.2%
[Analyst] Revisions Ratio: -0.18 (7 Up / 10 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.7% (Discount Rate 9.2% - Earnings Yield 5.6%)
[Growth] Growth Spread = +4.3% (Analyst 8.0% - Implied 3.7%)
P/E Forward = 12.8205
P/S = 5.2191
P/B = 6.0137
P/EG = 4.4197
Revenue TTM = 669.1m USD
EBIT TTM = 232.9m USD
EBITDA TTM = 247.4m USD
Long Term Debt = 52.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 7.32m USD (from shortTermDebt, last quarter)
Debt = 97.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -153.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.14b USD (3.49b + Debt 97.2m - CCE 445.9m)
Interest Coverage Ratio = -16.68 (Ebit TTM 232.9m / Interest Expense TTM -14.0m)
EV/FCF = 10.33x (Enterprise Value 3.14b / FCF TTM 304.4m)
FCF Yield = 9.68% (FCF TTM 304.4m / Enterprise Value 3.14b)
FCF Margin = 45.49% (FCF TTM 304.4m / Revenue TTM 669.1m)
Net Margin = 29.64% (Net Income TTM 198.3m / Revenue TTM 669.1m)
Gross Margin = 82.85% ((Revenue TTM 669.1m - Cost of Revenue TTM 114.8m) / Revenue TTM)
Gross Margin QoQ = 83.36% (prev 83.64%)
Tobins Q-Ratio = 2.87 (Enterprise Value 3.14b / Total Assets 1.10b)
Interest Expense / Debt = 2.24% (Interest Expense 2.18m / Debt 97.2m)
Taxrate = 17.50% (11.3m / 64.4m)
NOPAT = 192.1m (EBIT 232.9m * (1 - 17.50%))
Current Ratio = 1.41 (Total Current Assets 657.6m / Total Current Liabilities 467.3m)
Debt / Equity = 0.17 (Debt 97.2m / totalStockholderEquity, last quarter 561.2m)
Debt / EBITDA = -0.62 (Net Debt -153.0m / EBITDA 247.4m)
Debt / FCF = -0.50 (Net Debt -153.0m / FCF TTM 304.4m)
Total Stockholder Equity = 524.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 19.17% (Net Income 198.3m / Total Assets 1.10b)
RoE = 37.83% (Net Income TTM 198.3m / Total Stockholder Equity 524.2m)
RoCE = 40.40% (EBIT 232.9m / Capital Employed (Equity 524.2m + L.T.Debt 52.3m))
RoIC = 36.65% (NOPAT 192.1m / Invested Capital 524.2m)
WACC = 9.04% (E(3.49b)/V(3.59b) * Re(9.24%) + D(97.2m)/V(3.59b) * Rd(2.24%) * (1-Tc(0.18)))
Discount Rate = 9.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.15%
[DCF] Terminal Value 76.11% ; FCFF base≈275.4m ; Y1≈307.5m ; Y5≈406.1m
[DCF] Fair Price = 166.9 (EV 5.80b - Net Debt -153.0m = Equity 5.95b / Shares 35.7m; r=9.04% [WACC]; 5y FCF grow 13.52% → 2.90% )
EPS Correlation: 96.16 | EPS CAGR: 21.90% | SUE: 1.87 | # QB: 16
Revenue Correlation: 98.98 | Revenue CAGR: 12.31% | SUE: 1.22 | # QB: 2
EPS next Quarter (2026-06-30): EPS=1.79 | Chg7d=-0.014 | Chg30d=-0.013 | Revisions Net=-3 | Analysts=22
EPS current Year (2026-12-31): EPS=7.38 | Chg7d=+0.000 | Chg30d=-0.002 | Revisions Net=+2 | Growth EPS=+4.4% | Growth Revenue=+7.8%
EPS next Year (2027-12-31): EPS=7.98 | Chg7d=+0.000 | Chg30d=+0.122 | Revisions Net=+7 | Growth EPS=+8.1% | Growth Revenue=+7.2%
[Analyst] Revisions Ratio: -0.18 (7 Up / 10 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.7% (Discount Rate 9.2% - Earnings Yield 5.6%)
[Growth] Growth Spread = +4.3% (Analyst 8.0% - Implied 3.7%)